Comparison of efficacy of different treatments for pulmonary embolism

Abstract

An optimal therapy for pulmonary embolism (PE) was explored by comparing three different methods in order to alleviate the sufferings of PE patients and reduce the mortality. Eighty patients with PE diagnosed by computed tomography angiography (CTA) were treated with thrombolysis, anticoagulation only, or surgery/intervention. The clinical efficacy of different treatments were compared and analyzed. Twenty-four out of the 26 patients (92%) in anticoagulation only group showed improvement in CTA and clinical presentations, which was significantly higher than that in the thrombolysis group (87%, n=39, P<0.05). However, there was no significant difference in the rate of mortality between thrombolysis group and anticoagulation only group. In the surgery/interventional group (n=15), the success rate was 47%, and the mortality rate was 14%. Both of them were significantly different from those in thrombolysis and anticoagulation only groups (both P<0.05). Log-rank analysis of the data of 5-year follow-up revealed that the survival time in surgery/intervention group was significantly shorter than in the other two groups (P<0.05). It was suggested that it is of importance to choose the appropriate therapeutic regimen for PE patients. Mortality may be reduced and prognosis may be improved with anticoagulation only and thrombolysis therapy.

Keywords

pulmonary embolism / treatment choice / evaluation of therapeutic efficacy / anticoagulation / thrombolysis

References

[1] AklogL, WilliamsCS, ByrneJG, et al. . Acute pulmonary embolectomy: a contemporary approach. Circulation, 2002, 105(12): 1416-1419 PMID: 11914247

[2] WolfTR, AllenTL. Syncope as an emergency department presentation of pulmonary embolism. J Emerg Med, 1998, 16(1): 27-31

[3] KasperDL, BraunwaldE, FauciAS, et al. . Pulmonary thromboembolism. Harrison’s Principles of Internal Medicine, 2005, New York, NY, McGraw-Hill, 1561-1565

[4] AdamT, GiancarloA, NicolasD, et al. . Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J, 2014, 35: 3033-3080

[5] LiangY, YangJH, LiuS, et al. . Assessment of treatment regimens in 58 cases of acute pulmonary embolism. Chin J Tuberc Respir Dis (Chinese), 2000, 23(4): 235-238

[6] MosbeckA. Diagnosis of lung embolism. Acta Med Austriaca, 1993, 200(1): 32-35

[7] RahimtoolaA, BerginJD. Acute pulmonary embolism: an update on diagnosis and management. Curr Probl Cadiol, 2005, 30: 61-114

[8] AndersonFAJr, SpencerFA. Risk factors for venous thromboembolism. Circulation, 2003, 207: 9-16

[9] ChengXS. Pulmonary vascular disease (Chinese), 1993, Beijing, Joint Publishing House of Beijing Medical College and Beijing Union Medical College, 179-195

[10] ZhangHD. Clinical treatment of pulmonary embolism. J Clin Exper Med, 2010, 9(12): 953-954

[11] GanLH, ZhangJQ, ZhangZG, et al. . Clinical analysis of surgical treatment of 54 cases of pulmonary embolism. Chin J Surg (Chinese), 2008, 46(1): 36-38

[12] WoodKE. Major pulmonary embolism—review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest, 2002, 121(3): 877-905 PMID: 11888976

[13] ZhangZG, GaoDF. Late progress in pulmonary embolism diagnosis. Med Recap, 2011, 17(11): 1684-1686

[14] MasottiL, RighiniM, VuilleumierN, et al. . Prognostic stratification of acute pulmonary embolism: focus on clinical aspects, imaging, and biomarkers. Vasc Health Risk Manag, 2009, 5(4): 567-575 PMID: 19649307 PMCID: 2710971

[15] VedovatiMC, GerminiF, AgnelliG, et al. . Prognostic role of embolic burden assessed at computed tomography angiography in patients with acute pulmonary embolism: systematic review and meta-analysis. Thromb Haemost, 2013, 11(12): 2092-2102

[16] GongXW, YuanYD. Meta-analysis of risk factors for all-cause mortality of pulmonary thromboembolism. Zhonghua Yi Xue Za Zhi (Chinese), 2013, 93: 2534-2540